Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fortis Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Fortis Biosciences

Fortis Biosciences

Fortis: A microbiome startup pioneering in biologic therapeutics through precise biomolecular research.

HQ
College Station, TX, US
Founded
2013
Overview
Compare
Fundraising
Employees

Fortis Biosciences is a translational microbiome startup dedicated to pioneering biologic therapeutics through precise biomolecular and genetic research. Their core mission is to explore endogenous microbiota-mediated mechanisms to develop next-generation biologic treatments. Fortis focuses on leveraging cutting-edge approaches to improve health outcomes.

Fortis has made significant strides in the biotech industry, translating their research into impactful therapeutic solutions. Their innovative work has positioned them as leaders in microbiome science, contributing to advancements in health and medicine.

Fortis Biosciences - Similar Companies

Fortis Therapeutics logo

Fortis Therapeutics

Forte Biosciences logo

Forte Biosciences

fortebiorx.com

Petri Bio logo

Petri Bio

petribio.com

Microbiome Therapeutics logo

Microbiome Therapeutics

MarvelBiome logo

MarvelBiome

marvelbiome.com

Federation Bio logo

Federation Bio

federation.bio

Omni Biosciences logo

Omni Biosciences

BridGene Biosciences logo

BridGene Biosciences

Biomiic logo

Biomiic

Biosortia Microbiomics logo

Biosortia Microbiomics

biosortia.com

MatriSys Bioscience logo

MatriSys Bioscience

matrisysbio.com

The BioCollective logo

The BioCollective

Naked Biome logo

Naked Biome

Scioto Biosciences logo

Scioto Biosciences

Notitia Biotechnologies logo

Notitia Biotechnologies

notitiabio.com

Fortis Biosciences - Quick Facts

Who are Fortis Biosciences' competitors?

Companies similar to Fortis Biosciences include Fortis Therapeutics, Forte Biosciences, Petri Bio and Microbiome Therapeutics.

When was Fortis Biosciences founded?

Fortis Biosciences was founded in 2013.

Where is Fortis Biosciences' headquarters located?

Fortis Biosciences' headquarters is located in College Station, TX, US.

When was Fortis Biosciences' last funding round?

Fortis Biosciences' most recent funding round was for $5k (USD) in May 2017.

How much has Fortis Biosciences raised to-date?

As of May 16, 2017, Fortis Biosciences has raised a total of $5k (USD).

How many employees does Fortis Biosciences have?

Fortis Biosciences has 1 employee as of Feb 4, 2024.

Fortis Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biologic Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software